CY1541A - Antidepressant 1,2,4-triazolone compounds - Google Patents

Antidepressant 1,2,4-triazolone compounds

Info

Publication number
CY1541A
CY1541A CY1541A CY154191A CY1541A CY 1541 A CY1541 A CY 1541A CY 1541 A CY1541 A CY 1541A CY 154191 A CY154191 A CY 154191A CY 1541 A CY1541 A CY 1541A
Authority
CY
Cyprus
Prior art keywords
antidepressant
triazolone compounds
triazolone
compounds
Prior art date
Application number
CY1541A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1541(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1541A publication Critical patent/CY1541A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY1541A 1983-09-30 1991-03-22 Antidepressant 1,2,4-triazolone compounds CY1541A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (1)

Publication Number Publication Date
CY1541A true CY1541A (en) 1991-03-22

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1541A CY1541A (en) 1983-09-30 1991-03-22 Antidepressant 1,2,4-triazolone compounds

Country Status (25)

Country Link
US (1) US4613600A (pt)
JP (1) JPS60100560A (pt)
KR (1) KR880002624B1 (pt)
AT (1) AT387963B (pt)
AU (1) AU561460B2 (pt)
BE (1) BE900714A (pt)
CA (1) CA1237723A (pt)
CH (1) CH661924A5 (pt)
CY (1) CY1541A (pt)
DE (1) DE3435745C2 (pt)
DK (1) DK169546B1 (pt)
ES (1) ES8601966A1 (pt)
FI (1) FI83310C (pt)
FR (1) FR2552759B1 (pt)
GB (1) GB2147297B (pt)
GR (1) GR80475B (pt)
HK (1) HK37391A (pt)
IE (1) IE58084B1 (pt)
IT (1) IT1178522B (pt)
LU (1) LU85561A1 (pt)
MY (1) MY102123A (pt)
NL (1) NL8402946A (pt)
SE (1) SE465928B (pt)
YU (1) YU45667B (pt)
ZA (1) ZA847589B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
US6384037B1 (en) 1999-04-09 2002-05-07 Sepracor Inc. R-hydroxynefazodone
US6465469B1 (en) 1999-04-09 2002-10-15 Sepracor Inc. S-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
US9072660B2 (en) 2011-09-09 2015-07-07 The Board Of Trustees Of The Leland Stanford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
US4613600A (en) 1986-09-23
DK169546B1 (da) 1994-11-28
DE3435745A1 (de) 1985-04-11
FR2552759A1 (fr) 1985-04-05
KR880002624B1 (ko) 1988-12-07
IT1178522B (it) 1987-09-09
GR80475B (en) 1985-01-31
DK468284A (da) 1985-03-31
AU3364884A (en) 1985-04-04
YU45667B (sh) 1992-07-20
AU561460B2 (en) 1987-05-07
IE842476L (en) 1985-03-30
ES536286A0 (es) 1985-11-16
KR850002270A (ko) 1985-05-10
IT8422922A0 (it) 1984-09-28
IE58084B1 (en) 1993-06-30
JPS60100560A (ja) 1985-06-04
AT387963B (de) 1989-04-10
DK468284D0 (da) 1984-09-28
CA1237723A (en) 1988-06-07
ATA310884A (de) 1988-09-15
FI83310B (fi) 1991-03-15
CH661924A5 (de) 1987-08-31
BE900714A (fr) 1985-03-28
GB2147297A (en) 1985-05-09
ZA847589B (en) 1985-05-29
YU172184A (en) 1986-10-31
FI843779A0 (fi) 1984-09-26
FR2552759B1 (fr) 1988-10-07
ES8601966A1 (es) 1985-11-16
LU85561A1 (fr) 1985-06-04
DE3435745C2 (de) 1994-11-03
NL8402946A (nl) 1985-04-16
MY102123A (en) 1992-03-31
FI83310C (fi) 1991-06-25
FI843779L (fi) 1985-03-31
SE8404869L (sv) 1985-03-31
GB2147297B (en) 1987-04-15
HK37391A (en) 1991-05-24
GB8424535D0 (en) 1984-11-07
SE8404869D0 (sv) 1984-09-28
JPH0542435B2 (pt) 1993-06-28
SE465928B (sv) 1991-11-18

Similar Documents

Publication Publication Date Title
GB2147297B (en) Antidepressant 1,2,4-triazolone compounds
ZA847535B (en) 1,3-diaryl-5-methylene-perhydropyrimidin-2-ones
PH22446A (en) 1,2,4-triazolo-carbamate compounds
CS604984A2 (en) Zpusob tepelneho stepeni 1,2 dichloretanu
GB2160525B (en) 8,10-dideazaminopterins
GB2140007B (en) 1,8-dihydroxy-10-acyl-9-anthrones
CS620984A2 (en) Zpusob izolace 2-naftylamin-3,6,8-trisulfonove kyseliny
GB8319859D0 (en) 1,1,1-azidodinitro compounds
GB2156354B (en) 1,23-dihydroxyvitamin d compounds
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
PH20354A (en) Novel substituted tetrahydrothiopyran-3,5-dione-4-carboxamide fungicides
DE3468859D1 (en) Substituted 5-cycloalkyl-2,2-dimethyl-pentan-3-one
CS648483A1 (en) Sposob vyroby 2,2 azobisizobutyronitrilu
CS760383A1 (en) Sposob vyroby 1,1 azobisformamidu
CS378583A1 (en) Sposob vyroby 1,1 azobisformamidu
IL68335A (en) 1,3,5-triacrylylhexahydro-s-triazine derivatives
CS1024484A2 (en) Zpusob vyroby 3,4,5 trimethoxybenzonitrilu
DE3468029D1 (en) Novel compound, arugomycin
EP0136589A3 (en) 12, 16-difluoroprostaglandin f2 alpha compounds
CS244483A1 (en) Zpusob pripravy 2,2 dinaftylsulfonu
CS847583A1 (en) Zpusob cisteni 2,6 dimetylfenolu
IE831089L (en) 1,3-dioxolanylazoles
IL84947A (en) 1,2,3,5-tetra-o-acylribofuranosides
CS417083A1 (en) Zpusob pripravy 1 fenyl 1,3 propandiolu
GB8411538D0 (en) 2,6-diamino-3-cyanopyridine